Department of Nephrology, Radboud Institute of Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
CESP, INSERM, Université Paris-Sud, UVSQ, Université Paris-Saclay, Villejuif, France.
Nephrol Dial Transplant. 2020 May 1;35(5):819-827. doi: 10.1093/ndt/gfy278.
Glomerular filtration rate (GFR) is commonly used to monitor chronic kidney disease (CKD) progression, but its validity for evaluating kidney function changes over time has not been comprehensively evaluated. We assessed the performance of creatinine-based equations for estimating GFR slope according to patient characteristics and specific CKD diagnosis.
In the NephroTest cohort study, we measured GFR 5324 times by chromium 51-labeled ethylenediamine tetraacetic acid renal clearance in 1955 adult patients with CKD Stages 1-4 referred to nephrologists (Stages 1-2, 19%) and simultaneously estimated GFR with both the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) equations for isotope dilution mass spectrometry traceable creatinine; absolute and relative GFR slopes were calculated using a linear mixed model.
Over a median follow-up of 3.4 [interquartile range (IQR) 2.0-5.6] years, the decline in mean absolute and relative measured GFR (mGFR) and CKD-EPI and MDRD estimated GFR (eGFR) was 1.6 ± 1.2, 1.5 ± 1.4 and 1.3 ± 1.3 mL/min/1.73 m2/year and 5.9 ± 5.3, 5.3 ± 5.3 and 4.8 ± 5.2%/year, respectively; 52% and 55% of the patients had MDRD and CKD-EPI eGFR slopes within 30% of mGFR slopes. Both equations tended to overestimate the GFR slope in the youngest patients and underestimate it in the oldest, thus producing inverse associations between age and mGFR versus eGFR slope. Other patient characteristics and specific CKD diagnoses had little effect on the performance of the equations in estimating associations.
This study shows little bias, but poor precision in GFR slope estimation for both MDRD and CKD-EPI equations. Importantly, bias strongly varied with age, possibly due to variations in muscle mass over time, with implications for clinical care and research.
肾小球滤过率(GFR)常用于监测慢性肾脏病(CKD)的进展,但它在评估肾功能随时间变化方面的有效性尚未得到全面评估。我们根据患者特征和特定 CKD 诊断评估了基于肌酐的方程来估计 GFR 斜率的性能。
在 NephroTest 队列研究中,我们在 1955 名 CKD 1-4 期的成年患者中,通过铬 51-标记的乙二胺四乙酸肾清除率 5324 次测量 GFR,同时使用慢性肾脏病流行病学协作(CKD-EPI)和改良饮食在肾脏病(MDRD)方程同时估算 GFR 同位素稀释质谱痕量肌酐;使用线性混合模型计算绝对和相对 GFR 斜率。
中位数随访 3.4 年(IQR 2.0-5.6)期间,平均绝对和相对测量 GFR(mGFR)和 CKD-EPI 和 MDRD 估计 GFR(eGFR)的下降分别为 1.6±1.2、1.5±1.4 和 1.3±1.3 mL/min/1.73 m2/年和 5.9±5.3、5.3±5.3 和 4.8±5.2%/年;52%和 55%的患者 MDRD 和 CKD-EPI eGFR 斜率在 mGFR 斜率的 30%以内。两种方程在最年轻的患者中往往高估 GFR 斜率,在最年长的患者中低估 GFR 斜率,从而导致 mGFR 与 eGFR 斜率之间呈反比关系。其他患者特征和特定 CKD 诊断对方程估计关联的性能影响不大。
本研究表明,MDRD 和 CKD-EPI 方程在估计 GFR 斜率方面几乎没有偏差,但精度较差。重要的是,偏倚随年龄变化很大,可能是由于随时间推移肌肉质量的变化,这对临床护理和研究有影响。